MedPath

se of transthoracic echocardiography with agitated saline injection to detect transpulmonary shunting and Hepatopulmonary Syndrome in patients with advanced liver disease awaiting liver transplantatio

Completed
Conditions
Digestive System: Liver disease
Digestive System
Liver disease
Registration Number
ISRCTN82828072
Lead Sponsor
Record Provided by the NHSTCT Register - 2005 Update - Department of Health (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Current inclusion criteria as of 19/09/2007:
1. Potential research participants will be identified prospectively from all those admitted electively for transplant assessment to the University Hospital Birmingham over a one year period
2. They will be approached on the morning of admission to hospital. They will be given a patient information leaflet and have an opportunity to ask questions. Consent will not be taken at this time
3. Echocardiograms for pre-transplant assessment are performed on a Monday afternoon. Before the start of the test potential research participants will be approached and given an opportunity to ask further questions. At their satisfaction, they will be asked to sign a consent form if willing to participate
4. Patients electively admitted to UHB Liver Unit for assessment as to suitability for liver transplantation

Previous inclusion criteria:
Potential research participants will be all patients electively admitted to the Liver Transplantation Programme of the University Hospital Birmingham over a 6 month period from 01/10/2004 for pretransplant assessment. Prospective participants will be identified by review of elective admission lists, and will be approached by one of the investigators (RS) on the morning of admission to hospital. At this time they will be given the relevant information sheet and have an opportunity to ask questions. Consent will not be taken at this time.

The echocardiograms are performed later that day, and before the test patients will again have the opportunity to ask questions. The consent form will then be signed at this time if the patient is willing to participate.

Exclusion Criteria

Not provided at time of registration.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath